Georgetown University
Clinical trials sponsored by Georgetown University, explained in plain language.
-
Cancer drug tested for rare nerve disorder
Disease control TerminatedThis study aimed to see if a medication called daratumumab could help improve nerve damage (peripheral neuropathy) in adults with a specific blood condition called MGUS. The trial planned to give participants injections of the drug over six months and measure changes in nerve fun…
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
Can a simple walking plan tame metabolic risks for people with HIV?
Disease control OngoingThis study is testing whether a 6-month home-based walking program can improve metabolic health markers like blood sugar and cholesterol in people with and without HIV. Participants will gradually increase their daily steps to about 10,000, tracked with an activity monitor. The g…
Phase: NA • Sponsor: Georgetown University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Can talking to a peer coach help young women cope with inherited cancer risk?
Disease control OngoingThis study is testing whether telephone counseling from a trained peer coach can help young women with a strong family history of breast cancer. The program aims to reduce stress, help with decision-making about genetic testing, and provide emotional support. It compares this pee…
Phase: NA • Sponsor: Georgetown University • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Three-Pronged attack on advanced skin cancer tested in new trial
Disease control OngoingThis study is testing whether adding a drug called cabozantinib to two existing immunotherapy drugs (nivolumab and ipilimumab) can better control advanced melanoma that cannot be removed by surgery. The main goal is to see if this combination helps patients live longer without th…
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New combo therapy tested for Tough-to-Treat lung cancer
Disease control OngoingThis study is testing whether adding a new drug called tiragolumab to two existing cancer drugs (atezolizumab and bevacizumab) can help control advanced non-squamous lung cancer that has worsened after prior treatment. It will enroll about 29 adults whose cancer has specific gene…
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for Tough-to-Treat bile duct cancer when standard therapy fails
Disease control OngoingThis study is testing whether a combination of three chemotherapy drugs can help control advanced bile duct or gallbladder cancer that has worsened after initial treatment. It will involve about 48 patients whose cancer progressed despite standard gemcitabine and platinum chemoth…
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New combo therapy trial offers hope for tough pancreatic cancer
Disease control OngoingThis study is testing whether combining two drugs, BXCL701 and pembrolizumab, can help control metastatic pancreatic cancer that has worsened after initial treatment. It will measure if patients' cancer stays stable or shrinks for at least 18 weeks. The trial is for adults with a…
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Two-Drug attack on Tough-to-Treat blood cancer
Disease control OngoingThis study is testing a combination of two drugs, venetoclax and rituximab, for adults with chronic lymphocytic leukemia (CLL) that has returned or stopped responding to other treatments. The goal is to see how well and how safely this drug pair can control the cancer. Researcher…
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Video games help girls with rett syndrome regain arm control
Symptom relief OngoingThis study is testing whether a 6-month video game training program can help girls with Rett syndrome improve their ability to use their arms purposefully. The program aims to reduce repetitive hand movements that interfere with daily activities. Participants play specially desig…
Phase: NA • Sponsor: Georgetown University • Aim: Symptom relief
Last updated Mar 20, 2026 14:47 UTC
-
Web program aims to unlock Life-Saving BRCA info for families
Knowledge-focused ENROLLING_BY_INVITATIONThis study is testing a new, easier way to help family members of people with a BRCA gene mutation learn about genetic testing. It compares a web-based education program followed by a short phone call to the usual way information is shared. The goal is to see if this approach hel…
Phase: NA • Sponsor: Georgetown University • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC